Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun;5(6):311-22.
doi: 10.1038/nrneurol.2009.54.

Brain-derived Neurotrophic Factor in Neurodegenerative Diseases

Affiliations
Review

Brain-derived Neurotrophic Factor in Neurodegenerative Diseases

Chiara Zuccato et al. Nat Rev Neurol. .

Abstract

Changes in the levels and activities of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), have been described in a number of neurodegenerative disorders, including Huntington disease, Alzheimer disease and Parkinson disease. It is only in Huntington disease, however, that gain-of-function and loss-of-function experiments have linked BDNF mechanistically with the underlying genetic defect. Altogether, these studies have led to the development of experimental strategies aimed at increasing BDNF levels in the brains of animals that have been genetically altered to mimic the aforementioned human diseases, with a view to ultimately influencing the clinical treatment of these conditions. In this article, we will review the current knowledge about the involvement of BDNF in a number of neurodegenerative diseases, with particular emphasis on Huntington disease, and will provide the rationale for and discuss the problems in proposing BDNF treatment as a beneficial and feasible therapeutic approach in the clinic.

Similar articles

See all similar articles

Cited by 263 articles

See all "Cited by" articles

References

    1. Folia Neuropathol. 2006;44(1):12-6 - PubMed
    1. Neuroreport. 1996 Nov 25;7(18):2925-8 - PubMed
    1. Exp Neurol. 2005 Jul;194(1):91-6 - PubMed
    1. Neuron. 2006 Feb 2;49(3):341-8 - PubMed
    1. Neuropsychobiology. 2004;49(1):10-2 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback